96 Tests PN: B112497

32 Tests PN: A112497T


45x Ab-conjugated beads (S5P3 - human MCP-3 ab-bead).

  • 96 Tests PN: B112497A. One vial containing 100 µL of anti-human MCP-3 conjugated to AimPlex Bead S5P3.

  • 32 Tests PN: A112497TA. One vial containing 35 µL of anti-human MCP-3 conjugated to AimPlex Bead S5P3.

25x Biotin-detection Ab (human MCP-3 Biotin-dAb).

  • 96 Tests PN: B112497B. One vial containing 100 µL of biotinylated anti-human MCP-3.

  • 32 Tests PN: A112497TB. One vial containing 35 µL of biotinylated anti-human MCP-3.

Lyophilized Standard Mix-Human Group 1 Panel B.

  • 96 & 32 Tests PN: HG10011. One vial containing lyophilized recombinant Eotaxin, IL-1β, IL-1RA, IL-8, IL-12p70, IL-22, IP-10, MCP-1, MCP-3, and RANTES. Note: If multiple analyte kits on the above target list are ordered as a panel, only one vial of standard mix is supplied for those analyte kits. 

Application: Optimal antibody pair and antigen standard for assaying human CCL7/SCYA7/MCP-3.  Can be multiplexed with other analytes in Human Group 1.  To be used in conjunction with the AimPlex NR Basic Kit (96 Tests PN: P100001, 32 Tests PN: P100001T) and a diluent kit. Refer to the AimPlex Multiplex Immunoassay User Manual and kit inserts for the assay procedure.

Storage:  2-8 C in the dark.

Important: Sodium azide forms explosive compounds with heavy metals. These products contain <0.05% (w/w) azide which with repeated contact with lead and copper commonly found in plumbing drains may result in the buildup of shock sensitive compounds. Dispose in accordance with regulations from your institute.

For Research Use Only.  Not for use in diagnostic procedures.

Assay Specifications:

  • Sample types: Cell culture supernatant, serum, plasma, bodily fluid and tissue/cell lysate

  • Sensitivity (LOD): < 2 pg/mL

  • Quantitation range:

  • LLOQ: <5 pg/mL

  • ULOQ: > 5,000 pg/mL

  • Standard dose recovery: 70-130%

  • Intra-assay CV: < 10%

  • Inter-assay CV: < 20%

  • Cross-reactivity of analytes in Human Group 1: Negligible

  • Sample volume: 15 µL/test


CCL7, previously named MCP-3 (Accession P80098 ) is a member of the MCP subgroup of CC chemokines. It is produced by tumor cell lines and macrophages. CCL7 attracts neutrophils and monocytes. CCL7 participates in anti-inflammatory responses and can promote tumor progression, though there is research to suggest that it may hinder tumor proliferation under certain circumstances. Beyond cancer in adipose tissue, diseases correlated to the detection of CCL7 include demyelinating disease and nephrogenic systemic fibrosis.


  1. Combadiere C, Ahuja SK, Van Damme J, Tiffany HL, Gao J, Murphy PM. Monocyte Chemoattractant Protein-3 is a Functional Ligand for CC Chemokine Receptors 1 and 2B. J. Bio. Chem. 1995; 270: 29671-29675. Doi:10.1074/jbc.270.50.29671.

  2. Liu Y, Cai Y, Liu L, Wu Y, Xiong X. Crucial biological functions of CCL7 in cancer. Peer J 6:e4928. 2018. Doi: 10.7717/peerj.4928.

  3. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science. 2000; 289(5482): 1202-6. Doi:10.1126/science.289.5482.1202.